| Literature DB >> 8603382 |
D Bartsch1, S L Peiffer, Z Kaleem, S A Wells, P J Goodfellow.
Abstract
Amplification of the c-myc oncogene occurs in a variety of solid tumors, including pancreatic adenocarcinomas. The MXI1 gene, located at 10q24-q25, may serve to negatively regulate c-myc oncogene activity, and potentially has tumor suppressor function. As such, altered MXI1 function might contribute to tumorigenesis. We examined 40 primary human pancreatic adenocarcinomas for MXI1 mutations. Single-strand conformation variant analysis and direct sequencing of the variants revealed a MXI1 polymorphism in 1 of 40 tumors. No MXI1 mutations were identified. Southern blot analyses did not reveal any gross rearrangements of MXI1. These results suggest that MXI1 is unlikely to play a role in human pancreatic adenocarcinoma tumorigenesis.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8603382 DOI: 10.1016/0304-3835(96)04167-5
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679